Written by Dr. Kenneth Thorpe FDA regulators recently approved several revolutionary new medicines to fight heart disease, America’s leading cause of death. According to a recent study in the New England Journal of Medicine, the new class of drugs known as PCSK9 inhibitors can reduce harmful cholesterol by as much as 60 percent, a potential … Continue reading Overcharging for heart disease medication puts insurers before patients